Synthomics (Acquired in 2020)
Menlo Park
About Synthomics (Acquired in 2020)
Acquired 2020. Synthomics' distributed synthesis model places the power of DNA and RNA synthesis directly in the hands of the end-user. Leveraging multiple innovations in instrumentation and consumables, the technology empowers laboratories to fuel more rapid innovation in biological discovery.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $2.1M
- Funding stage: Seed
- Last round: Seed (Dec 2017)
- Website: synthomics.com
Industries & Categories
Biotechnology, Genetics, Life Science
Social Profiles
Canonical: https://fsome.com/organization/synthomics-acquired-in-2020-120339 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.